Skip to content

Lipidomic examinations in a drop of blood

Lipidomic examinations in a drop of blood - DBS-Lipotype

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00022027
Enrollment
2500
Registered
2020-06-03
Start date
2019-07-22
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular diseases E66 E11 E78

Interventions

Group 1: Patients with at least one of the following diseases: obesity, obesity with comorbidity, type 2 diabetes, cardiovascular disease, hyperlipidemia Group 2: Control subjects without the above di

Sponsors

Universitätsklinikum DresdenInstitut für Klinische Chemie und Laboratoriumsmedizin
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: • Ability to give consent and signed declaration of consent • Age between 18-80 years • At least one of the following diseases: obesity, obesity with comorbidity, type 2 diabetes, cardiovascular disease, hyperlipidemia • Another cohort (control group 1) are outpatients or inpatients who do not have any of the above 5 diseases, but another disease • In addition, a group of healthy volunteers is included (control group 2)

Exclusion criteria

Exclusion criteria: Pregnant and breastfeeding women

Design outcomes

Primary

MeasureTime frame
The aim of the study is to check whether the method is suitable for use in clinical studies.

Countries

Germany

Contacts

Public ContactOliver;Gesine Tiebel;Flehmig

Universitätsklinikum DresdenInstitut für Klinische Chemie und Laboratoriumsmedizin;Universitätsklinikum LeipzigKlinik und Poliklinik für Endokrinologie und Nephrologie

oliver.tiebel@uniklinikum-dresden.de;gesine.flehmig@medizin.uni-leipzig.de+49(0) 351 458 4805;0341 97 15370

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026